Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival | Newswise Newswise
10 Bladder and Urothelial Cancer Trials to Watch at ESMO 2026 Oncodaily
Oregon Surgical Wellness adds breast surgical oncologist Sara B. Cartwright to team KMTR
Louis Vermeulen Appointed Global Head of Oncology at Roche pRED Oncodaily
Cancer mortality for individuals aged under 50 years in Canada has significantly decreased for nine of the 10 deadliest malignancies since 2000. “This is a great news story,” Darren R. Brenner, PhD, professor at Cumming School of Medicine at University of Calgary, told Healio. However, colorectal cancer mortality has…
LSU Health New Orleans recruits internationally recognized leader to establish institution’s first academic department of radiation oncology EurekAlert! Science News Releases
Lived Experience Hub Event Opportunity: Symposium on Clinical Insights in Cancer Genome Interpretation Oncodaily
Сигаретный дым готовит стволовые клетки легких к раку Наука Mail
CPRIT honors Zhiqiang An for cancer research | Newswise Newswise
Tumor Traits May Predict Who Responds to Lighter HER2+ Breast Cancer Chemo Cure Today
A randomized phase 2B trial of a novel peptide-based vaccine missed its primary endpoint, as the immunotherapy failed to significantly extend survival compared with placebo in newly diagnosed glioblastoma, according to a press release. However, topline data showed SurVaxM (MimiVax Inc.) may have the potential to delay…
FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Metastatic Breast Cancer Pharmaceutical Executive
Tennessee Oncology Physician Contributes to Landmark Longevity Research PR Newswire
